FDA Inspection 1102870 — Jiangsu Grand Xinyi Pharmaceutical Co., Ltd
The FDA completed an inspection of Jiangsu Grand Xinyi Pharmaceutical Co., Ltd on September 12, 2019 in Yancheng. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 12, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Yancheng (China)